Domov › Rak prostate › Texas › Houston
Klinične študije za Rak prostate v Houston, TX
76 študij za Rak prostate išče udeležence na lokacijah v Houston in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Research Site, Houston
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Vključevanje udeležencevFaza 2
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Vključevanje udeležencevFaza 3
- Houston Metro Urology (HMU), Houston
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Vključevanje udeležencevFaza 1
- University of Texas MD Anderson Cancer Center, Houston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- UT MD Anderson Cancer Center, Houston
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- The University of Texas MD Anderson Cancer Center, Houston
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Vključevanje udeležencevFaza 1
- MD Anderson Cancer Center, Houston
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1/2
- MD Anderson Cancer Center, Houston
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
Vključevanje udeležencevZgodnja faza 1
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Vključevanje udeležencevFaza 3
- Texas Oncology - Gulf Coast ( Site 8002), Houston
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
Vključevanje udeležencev
- M D Anderson Cancer Center, Houston
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Research Site, Houston
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- NEXT Houston, Houston
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Vključevanje udeležencevFaza 1
- MD Anderson Cancer Center, Houston
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Vključevanje udeležencevFaza 3
- Renovatio Clinical, Houston
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Vključevanje udeležencevFaza 3
- Research Site, Houston
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
Vključevanje udeležencevFaza 1/2
- MD Anderson Cancer Center, Houston
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Vključevanje udeležencevFaza 2
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Vključevanje udeležencevFaza 3
- University of Texas-MD Anderson Cancer Center ( Site 0055), Houston
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- University of Texas MD Anderson Cancer Center, Houston
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Vključevanje udeležencevFaza 3
- UT MD Anderson Cancer Center, Houston
- MD Anderson West Houston, Houston
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Vključevanje udeležencevFaza 1
- Investigational Site Number: 401, Houston
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- UT MD Anderson, Houston
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Research Site, Houston
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Vključevanje udeležencevFaza 3
- Research Site, Houston
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
Vključevanje udeležencevFaza 1/2
- M D Anderson Cancer Center, Houston
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- University of Texas MD Anderson Cancer Center, Houston
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Vključevanje udeležencevFaza 1/2
- Oncology Consultants, P.A, Houston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Vključevanje udeležencevFaza 2
- Oncology Consultants, Houston
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Vključevanje udeležencevFaza 2
- U.T. MD Anderson Cancer Center, Houston
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
Vključevanje udeležencevFaza 1
- The University of Texas M. D. Anderson Cancer Center, Houston
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Vključevanje udeležencev
- The University of Texas MD Anderson Cancer Center, Houston
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Vključevanje udeležencevFaza 1
- Houston Methodist Hospital, Houston
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance
Vključevanje udeležencevOpazovalna študija
- M D Anderson Cancer Center, Houston
A Study of DM002 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
IDOV-Immune for Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- MD Anderson Cancer Center, Houston
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Vključevanje udeležencevFaza 3
- MD Anderson Cancer Center, Houston
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
Vključevanje udeležencevFaza 1/2
- M D Anderson Cancer Center, Houston
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Vključevanje udeležencevFaza 2
- UT MD Anderson Cancer Center, Houston
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Vključevanje udeležencevFaza 3
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- Ben Taub General Hospital, Houston
- Houston Methodist Hospital, Houston
- in še 4
Stem Cells for Erectile Dysfunction Post RALP
Vključevanje udeležencevFaza 1/2
- Houston Methodist, Houston
Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
Vključevanje udeležencev
- The University of Texas M. D. Anderson Cancer Center, Houston
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
Vključevanje udeležencevFaza 2
- M D Anderson Cancer Center, Houston
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Vključevanje udeležencevFaza 2
- Michael E. DeBakey VA Medical Center, Houston
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
Vključevanje udeležencevFaza 2
- M D Anderson Cancer Center, Houston
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Next Oncology - Houston, Houston
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Vključevanje udeležencevFaza 4
- UT Health Science Center, Houston
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
Vključevanje udeležencevFaza 2
- MD Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- MD Anderson Cancer Center, Houston
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
Vključevanje udeležencevOpazovalna študija
- M D Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Vključevanje udeležencev
- M D Anderson Cancer Center, Houston
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Vključevanje udeležencevFaza 2/3
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- MD Anderson Cancer Center, Houston
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Houston Methodist, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Vključevanje udeležencevOpazovalna študija
- Md Anderson Cancer Center, Houston
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Research Site, Houston
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Vključevanje udeležencevFaza 1
- MD Anderson Cancer Center, Houston
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Vključevanje udeležencevFaza 1
- Houston Metro Urology, Houston
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Vključevanje udeležencevFaza 3
- Lyndon Baines Johnson General Hospital, Houston
- M D Anderson Cancer Center, Houston
- MD Anderson West Houston, Houston
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Oncology Consultants, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
Vključevanje udeležencevFaza 2
- Ben Taub General Hospital, Houston
- Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Houston
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 3
- Lyndon Baines Johnson General Hospital, Houston
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- Ben Taub General Hospital, Houston
- in še 3
Comprehensive Assessment of Cancer Theranostic Response
Vključevanje udeležencev
- M.D. Anderson Cancer Center, Houston
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Exelixis Clinical Site #1, Houston
Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617
Vključevanje udeležencevFaza 2
- Excel Diagnostics & Nuclear Oncology Center, Houston
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Vključevanje udeležencevFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
Vključevanje udeležencevOpazovalna študija
- M.D. Anderson Cancer Center, Houston
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
Vključevanje udeležencevFaza 1/2
- MD Anderson Cancer Center, Houston
Comprehensive Outcomes for After Cancer Health
Vključevanje udeležencevVabljeni zdravi prostovoljci
- The University of Texas MD Anderson Cancer Center, Houston
- UT Health Houston, Houston
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
Vključevanje udeležencevFaza 2
- M D Anderson Cancer Center, Houston
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
Vključevanje udeležencevFaza 2
- Houston Methodist Hospital, Houston
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Houston Methodist, Houston
Študije za Rak prostate v drugih mestih
- New York City, NY103 študij
- Los Angeles, CA61 študij
- Boston, MA59 študij
- St. Louis, MO46 študij
- Chicago, IL45 študij
- San Francisco, CA45 študij
- Philadelphia, PA44 študij
- Baltimore, MD43 študij
- Nashville, TN43 študij
- Seattle, WA42 študij
- Washington, DC38 študij
- Dallas, TX36 študij
Druge študije v Houston
- Nemalicelični pljučni rak145 študij
- Rak dojke126 študij
- Rak (vse vrste)121 študij
- Metastatski rak104 študij
- Kolorektalni rak102 študij
- Rak jajčnikov89 študij
- Akutna mieločna levkemija85 študij
- Rak pljuč78 študij
- Rak endometrija68 študij
- Rak trebušne slinavke61 študij
- Melanom59 študij
- Ploščatocelični karcinom glave in vratu47 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.